CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer

Project: Research project

Project Details

Description

CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer
StatusFinished
Effective start/end date11/1/2112/31/23

Funding

  • UNIVERSITY OF WISCONSIN-MADISON
  • PROSTATE CANCER FOUNDATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.